The 1^st edition of the 3D PharmaPrint Healthcare Symposium will take place on Tuesday March 18^th in Rotterdam, The Netherlands.

The PharmaPrint Healthcare Symposium, a collaborative initiative by TNO and Erasmus Medical Center, seeks to bridge the gap between pharmaceuticals and healthcare through the lens of 3D printing. By uniting thought leaders and pioneers in the field, our objective is to shape the future of healthcare, fostering precision medicine, and pushing the boundaries of what’s achievable in the realm of healthcare. Our goal is to create a dynamic space for experts, researchers, and industry leaders to exchange insights, accelerate innovation, and pave the way for a future where personalized medicine meets cutting-edge technology.

Program
The preliminary program is available here.

Registration
For registration click on ‘Online registratie’ (right side of the page)
You can register for the symposium until February 28^th, 2025.

Venue

Buitenplaats Rozenlust
Parklaan 11
3016 BA Rotterdam
Website Rozenlust: https://rozenlust.nl/ 

Accreditation
Accreditation requested by NVZA en KNMP

Organisation

Liesbeth Ruijgrok

Liesbeth Ruijgrok is a hospital pharmacist and researcher that is highly motivated to improve the availability of suitable medicines for neglected patient groups. She has been working in Erasmus MC since 2018. She is Principal Investigator in the Research Pillar “Drug Innovation and Drug Development” of the Hospital Pharmacy. She is an enthusiastic collaborator in several scientific projects that concern in-academia development of drugs, varying from small molecules to cell therapy products (ATMP) and cancer vaccines. Since 2019 she has been working in the field of 3D-printing, in close collaboration with TNO. She sees that the 3D-printing technology can substantially enlarge personalized treatment options since it allows for flexible and tuneable drug compounding. She is affiliated to a growing Dutch and European consortium in this field and currently supervises 4 PhD students on the topic of 3D pharmaprinting. Her ultimate goal: to bring this exciting new technology as soon as possible to the benefit of patients!

Julian Quodbach

Julian Quodbach is a pharmacist by training with a PhD in pharmaceutics from Heinrich Heine University Düsseldorf in Germany. Since 2015 he is researching 3D printing as manufacturing tool for pharmaceutical products. After a postdoc at the Drug Delivery Group at Uppsala University, Sweden in 2019, Julian Quodbach returned to Düsseldorf to continue his work on 3D printing. In January 2022, Julian joined the Utrecht Institute for Pharmaceutical Sciences at Utrecht University, The Netherlands as Assistant Professor. There, he connects his academic work on 3D printing of medicines with clinical translation and application.

Jayeeta Sengupta

Dr. Jayeeta Sengupta is a biologist specializing in drug development, nanomedicine, and bridging research with business innovation. She has held both academic and industry positions globally in different organizations. She has contributed to impactful research and authored multiple publications. Her current role is Program Manager Science & Technology, Unit High Tech Industry at TNO.